SCHEMBL4846256

SCHEMBL4846256

Cc1ccccc1-c1ccc(OCCCCCN(C)C(C)(C)C)c(C=O)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A9 P48067 4/20 0.41
MAOB P27338 2/20 0.39
KDM4E B2RXH2 3/20 0.38
ALDH1A1 P00352 3/20 0.38
MAPT P10636 2/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
PTPN11 Q06124 1/20 0.37
MCHR1 Q99705 1/20 0.37
HTR2C P28335 1/20 0.36
HTR7 P34969 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
TSHR P16473 1/20 0.35
MAPK1 P28482 1/20 0.35
CYP2C19 P33261 1/20 0.35
CLK4 Q9HAZ1 1/20 0.35
NPY1R P25929 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4852357 0.99 SLC6A9 (0.42) SLC6A9MAOBKDM4EALDH1A1MAPT
SCHEMBL4851155 0.92 SLC6A9 (0.46) SLC6A9KDM4EALDH1A1MAPTMEN1
SCHEMBL4855017 0.88 KDM4E (0.49) SLC6A9KDM4EALDH1A1MAPTMEN1
SCHEMBL4852186 0.84 SLC6A9 (0.46) SLC6A9KDM4EALDH1A1MAPTMEN1
SCHEMBL4849739 0.83 ALDH1A1 (0.46) SLC6A9KDM4EALDH1A1MAPTMEN1
SCHEMBL4845580 0.83 SLC6A9 (0.49) SLC6A9KDM4EALDH1A1MAPTMEN1
SCHEMBL4846246 0.80 ALDH1A1 (0.42) SLC6A9KDM4EALDH1A1MAPTMEN1
SCHEMBL4853384 0.79 PTPN11 (0.37) SLC6A9MAOBKDM4EPTPN11
SCHEMBL4854461 0.78 DRD2 (0.46) SLC6A9MAOBKDM4EALDH1A1MAPT
SCHEMBL4854976 0.78 CYP1A2 (0.47) KDM4EALDH1A1MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7423181-B2 in particular against bacterial and parasitic infections, fungi, and helminths; improved metabolic and physiochemical properties, bioavailability, solubility; 3-[4-(2-Dimethylamino-ethoxy)-2'-trifluoromethyl-biphenyl-3-yl]-1-(2-dimethylaminomethyl-phenyl)-propenone LICA PHARMACEUTICALS A/S (DK) 2008-09-09 US disclosed
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US disclosed
EP-1515940-A2 AMINOALKOXY-FUNCTIONAL CHALCONES Lica Pharmaceuticals A/S (DK) 2005-03-23 EP disclosed
WO-2003097574-A2 AMINOALKOXY-FUNCTIONAL CHALCONES LICA PHARMACEUTICALS A/S (DK) 2003-11-27 WO disclosed